ILIANA DEL ORBE POLANCO: Open Payments
NPI 1821716747 · REIDSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$388 in 22 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $1,262 · 2025 $388
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $92 |
| ABBVIE INC. | 5 | $83 |
| Novo Nordisk Inc | 3 | $50 |
| Exact Sciences Corporation | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: Veozah, VRAYLAR, Cologuard Collection Kit, QULIPTA, Ozempic, CAPLYTA, Wegovy, Kerendia.
Industry payments across NC — which companies pay providers there.
